Ocera Therapeutics to Host KOL Conference Call on Hepatic Encephalopathy and Other Complications of Liver Disease on Friday, June 2
26 mai 2017 09h05 HE
|
Ocera Therapeutics, Inc.
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., May 26, 2017 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and...
Tranzyme Pharma to Present at BIO CEO & Investor Conference
07 févr. 2012 05h10 HE
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C., Feb. 7, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that Vipin K. Garg, Ph.D., President and CEO, will present at the BIO CEO & Investor...
Tranzyme Pharma Secures Additional $9.3 Million Debt Financing
01 févr. 2012 16h30 HE
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C., Feb. 1, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM) today announced that it received an additional net $9.3 million in term loan proceeds through an amendment...